Amedeo Smart

Free Medical Literature Service

 

Amedeo

Rheumatoid Arthritis
  Free Subscription

Articles published in
Curr Opin Rheumatol
    May 2024
  1. FOX DA
    Rheumatoid arthritis - the challenge of heterogeneity.
    Curr Opin Rheumatol. 2024;36:201-202.
    >> Share

  2. JOHNSON NM, Koumpouras F
    Chimeric antigen receptors: "CARs" in the fast lane for rheumatology.
    Curr Opin Rheumatol. 2024;36:176-183.
    >> Share

    March 2024
  3. DEANE KD
    Rheumatoid arthritis: prediction of future clinically-apparent disease, and prevention.
    Curr Opin Rheumatol. 2024 Mar 6. doi: 10.1097/BOR.0000000000001013.
    >> Share

  4. BARTH K, Gill H, Singh N
    Long-term safety of biologic and targeted synthetic disease modifying drugs in rheumatology.
    Curr Opin Rheumatol. 2024;36:113-119.
    >> Share

    February 2024
  5. STEINER G, Toes REM
    Autoantibodies in rheumatoid arthritis - rheumatoid factor, anticitrullinated protein antibodies and beyond.
    Curr Opin Rheumatol. 2024 Feb 27. doi: 10.1097/BOR.0000000000001006.
    >> Share

  6. MYASOEDOVA E, Matteson EL
    Updates on interstitial lung disease and other selected extra-articular manifestations of rheumatoid arthritis.
    Curr Opin Rheumatol. 2024 Feb 26. doi: 10.1097/BOR.0000000000001007.
    >> Share

  7. PARK E, Bathon J
    Cardiovascular complications of rheumatoid arthritis.
    Curr Opin Rheumatol. 2024 Feb 12. doi: 10.1097/BOR.0000000000001004.
    >> Share

    January 2024
  8. WALLACE BI, Cooney L, Fox DA
    New molecular targets in the treatment of rheumatoid arthritis.
    Curr Opin Rheumatol. 2024 Jan 3. doi: 10.1097/BOR.0000000000001000.
    >> Share

    November 2023
  9. COHEN S, Reddy V
    Janus kinase inhibitors: efficacy and safety.
    Curr Opin Rheumatol. 2023;35:429-434.
    >> Share

    September 2023
  10. NEUMANN E, Heck C, Muller-Ladner U
    Recent developments in the synovial fibroblast pathobiology field in rheumatoid arthritis.
    Curr Opin Rheumatol. 2023 Sep 13. doi: 10.1097/BOR.0000000000000978.
    >> Share

    May 2023
  11. DEFOE M, Bermas BL
    Rheumatologic immune checkpoint inhibitor-related adverse events.
    Curr Opin Rheumatol. 2023;35:141-148.
    >> Share

    April 2023
  12. MANTEL I, Fein MR, Donlin LT
    Emerging synovial cell states in rheumatoid arthritis as potential therapeutic targets.
    Curr Opin Rheumatol. 2023 Apr 10. doi: 10.1097/BOR.0000000000000940.
    >> Share

    February 2023
  13. MINHAS D, Murphy A, Clauw DJ
    Fibromyalgia and centralized pain in the rheumatoid arthritis patient.
    Curr Opin Rheumatol. 2023 Feb 13. doi: 10.1097/BOR.0000000000000929.
    >> Share

  14. ZACCARDELLI A, Wallace ZS, Sparks JA
    Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic.
    Curr Opin Rheumatol. 2023 Feb 8. doi: 10.1097/BOR.0000000000000930.
    >> Share

    November 2022
  15. KINGSMORE KM, Lipsky PE
    Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupus.
    Curr Opin Rheumatol. 2022;34:374-381.
    >> Share

    September 2022
  16. LORENTZON M, Abrahamsen B
    Osteoporosis epidemiology using international cohorts.
    Curr Opin Rheumatol. 2022;34:280-288.
    >> Share

    July 2022
  17. IZNARDO H, Puig L
    Beyond plaque psoriasis - pathogenesis and treatment of other psoriasis phenotypes.
    Curr Opin Rheumatol. 2022;34:225-234.
    >> Share

    May 2022
  18. LUIS M, Boers M, Saag K, Buttgereit F, et al
    The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence.
    Curr Opin Rheumatol. 2022;34:179-186.
    >> Share

    March 2022
  19. ANASTASIOU C, Yazdany J
    Review of publications evaluating opioid use in patients with inflammatory rheumatic disease.
    Curr Opin Rheumatol. 2022;34:95-102.
    >> Share

    November 2021
  20. BIRRU TALABI M, Himes KP, Clowse MEB
    Optimizing reproductive health management in lupus and Sjogren's syndrome.
    Curr Opin Rheumatol. 2021;33:570-578.
    >> Share

    September 2021
  21. SATTUI SE, Crow MK, Navarro-Millan I
    The role of immunomodulatory medications in the treatment of COVID-19.
    Curr Opin Rheumatol. 2021;33:431-445.
    >> Share

  22. RANDELL RL, Becker ML
    Safety updates in novel therapeutics for pediatric rheumatic disease.
    Curr Opin Rheumatol. 2021;33:403-408.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016